- The effect of low FODMAP diet with and without gluten on irritable bowel syndrome: A double blind, placebo controlled randomized clinical trial
- 49 IBS patients, randomized to a:
- Low FODMAP diet w/ gluten-free powder (rice powder)
- Or low FODMAP diet w/ gluten powder (5g/d)
- Both groups had similar rates of:
- Improved IBS symptoms (-32% gluten vs 49% gluten-free group)
- Abdominal pain intensity (-45% vs -52%)
- Abdominal pain frequency (-26% vs -46%)
- Distension (-29% vs -63%)
- Commentary: Even though there was a trend towards greater improvement in the gluten-free group, this difference was NOT statistically significant.
- 49 IBS patients, randomized to a:
- The effectiveness of rotating versus single course antibiotics for small intestinal bacterial overgrowth
- 223 patients w/ SIBO (by glucose breath test)
- Patients were treated either with a single antibiotic (quinolone or azole) or rotating antibiotics (quinolone and azole, one after the other) for 10 consecutive days per month for 3 months.
- The rotating antibiotic group had higher rate of clinical remission (70% vs 50.8%)
- Clinical remission was associated with an improvement in quality of life and bloating
- Commentary: Rotating antimicrobials may be superior for treating SIBO. This study showed an association between the eradication of SIBO and the improvement of quality of life and bloating.
- Efficacy of Probiotics in Rheumatoid Arthritis and Spondyloarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- 13 studies, including 344 patients w/ rheumatoid arthritis (RA) and 197 w/ spondyloarthritis (SpA)
- Examined effect of lactobacillus and Bacillus probiotics species
- Probiotic supplementation led to:
- Decrease in CRP (-3.04 mg/dL) in those w/ RA
- NO difference in those w/ SpA
- Commentary: In this meta-analysis, probiotics led to more improvement in those w/ RA as compared to those w/ SpA.
- Predictors of Symptom-Specific Treatment Response to Dietary Interventions in Irritable Bowel Syndrome
- Aim: Investigate predictors of symptom improvement after dietary change in those w/ IBS
- 67 IBS patients, randomized to low FODMAP diet or traditional diet x4 weeks
- Factors associated w/ more symptom improvement:
- Less severe dysbiosis (per GA-map Dysbiosis test)
- Higher energy intake at baseline (less food restriction)
- More psychological distress associated with LESS symptom improvement
- Commentary: Those who may respond better to a low FODMAP (or another IBS diet) include: those w/ less dysbiosis, less anxiety, and who are able to tolerate more foods at baseline.
- The Effects of One Anastomosis Gastric Bypass Surgery on the Gastrointestinal Tract
- Prospective study of 32 patients who all had one anastomosis gastric bypass (OAGB) bariatric surgery
- 6 months after surgery:
- Increase in SIBO positive (0% to 37%)
- SIBO was associated w/ lower fiber intake and higher vitamin A deficiency
- Increase in exocrine pancreatic insufficiency (0% to 26%)
- Decrease in microbial diversity
- Increase in SIBO positive (0% to 37%)
- Commentary: Relatively high rates of SIBO and exocrine pancreatic insufficiency were found after bariatric surgery at a 6 month follow up.
- Metabolic phenotypes and risk of colorectal cancer: a systematic review and meta-analysis of cohort studies
- Analysis of 7 cohorts, 760,000 participants
- Compared with healthy normal-weight people, those w/ obesity and/or have poor metabolic health have a higher rate of colorectal cancer (OR 1.19)
- This relationship was stronger for males than females
- Commentary: Being obese or having poor metabolic health is a risk factor for colorectal cancer.
- Fecal microbiota transplant as a potential treatment for Parkinson’s disease – A case series
- 6 patients w/ Parkinson’s disease, treated with FMT
- At a 4 week follow up: motor, non-motor, and constipation scores were improved in 5 of 6 patients
- 1 patient had an adverse event
- Yield of testing for micronutrient deficiencies associated with pancreatic exocrine insufficiency in a clinical setting: An observational study
- 112 patients w/ suspected maldigestion tested for exocrine pancreatic insufficiency (EPI) and micronutrient deficiencies
- 36.6% had EPI
- Those w/ EPI had a much higher rate of micronutrient deficiencies (41.5% EPI, vs 5.6% non-EPI)
- Most common micronutrient deficiencies: selenium, magnesium
- Commentary: Micronutrient deficiencies are relatively common in those w/ EPI.
- Additive effect of probiotics on 5-aminosalicylic acid therapy in patient with ulcerative colitis
- 118 patients w/ mild-to-moderate ulcerative colitis (UC)
- Randomized to E. coli Nissle 1917 probiotic or placebo
- After 8 weeks of supplementation, the probiotic group had:
- NO difference in IBD symptom score
- HIGHER clinical response (39.7% vs 21.7%)
- HIGHER endoscopic remission (46.4% vs 27.1%)
- Commentary: This study found that the probiotic, E. coli Nissle 1917 was effective in improving UC.
- The role of calcium and vitamin D dietary intake on risk of colorectal cancer: systematic review and meta-analysis of case-control studies
- 37 studies examining the effect of calcium and Vit D intake on colorectal cancer (CRC) risk
- 32 studies for calcium: 24,353 CRC cases, 30,650 controls
- 23 studies for Vit D: 19,076 CRC cases, 36,746 controls
- Higher dietary intake of calcium was associated w/ lower CRC (OR 0.94)
- Higher intake of Vit D was associated with w/ lower CRC (OR 0.96)
- Commentary: Higher intake of calcium and Vit D was associated with a slightly lower (4-6% reduction) risk of CRC.
- 37 studies examining the effect of calcium and Vit D intake on colorectal cancer (CRC) risk
- Vitamin D supplementation in people with IBS has no effect on symptom severity and quality of life: results of a randomised controlled trial
- 135 IBS patients, randomized to placebo or Vit D (3,000 IU/d)
- 60% of participants were vitamin D deficient or insufficient at baseline
- After 12 weeks, the Vit D group had:
- Higher Vit D blood levels
- NO difference in change of IBS symptoms score (-62 vs -75 in placebo)
- NO difference in quality of life (-7.7 vs -11.3 in placebo)
- Commentary: This study showed NO beneficial effect of Vit D for IBS.
- Effects of vitamin D supplementation on blood markers in ulcerative colitis patients: a systematic review and meta-analysis
- 7 studies, 539 participants, examining effect of Vit D on ulcerative colitis
- Vitamin D supplementation led to:
- Lower ESR (effect size -1.1)
- Lower CRP (-0.4)
- No difference in disease severity
- Commentary: Vit D supplementation led to improvement of inflammatory markers, but no change in disease activity in those w/ ulcerative colitis.
- The development of the cure of the functional intestinal disorder based on the differences of gut microbiota in aged patients: A randomized clinical trial
- 60 patients w/ chronic constipation, randomized to:
- Laxatives only
- Laxatives + probiotics
- After 12 weeks, the combined laxative + probiotics group had:
- No greater improvement in stool frequency or consistency
- 60 patients w/ chronic constipation, randomized to:
- Antibiotics for induction and maintenance of remission in ulcerative colitis: systematic review and meta-analysis
- 13 RCTs, 785 participants
- Compared to placebo, antibiotic administration resulted in a clinical improvement in those w/ ulcerative colitis (OR 1.74)
- Commentary: Antimicrobials may improve ulcerative colitis.
- Oral CBD-rich Cannabis Induces Clinical but Not Endoscopic Response in Patients with Crohn’s Disease, a Randomised Controlled Trial
- 56 patients w/ Crohn’s Disease (CD), randomized to placebo or oral CBD oil
- After 8 weeks of supplementation, the CBD group had:
- Lower disease activity
- More improvement in quality of life
- NO difference in endoscopic findings
- NO change in CRP, calprotectin
- Commentary: CBD supplementation led to improved symptoms and quality of life, with no change in endoscopic findings or inflammatory markers in those w/ CD.
- Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial
- 35 patients w/ active ulcerative colitis (UC) all had 2 weeks of antibiotics (amoxicillin, metronidazole, and doxycycline)
- Then randomized to placebo or FMT capsules x8 weeks
- After 8 weeks, those who responded to the FMT were randomized to withdrawal or continuation of FMT for another 48 weeks
- After 8 weeks of supplementation, the FMT group had:
- Higher rate of clinical and endoscopic remission (53% vs 15%)
- No difference in adverse event rate (67% vs 85%)
- Those who continued FMT x48 weeks had higher rate of remission (100% vs 0%)
- Commentary: FMT capsules are beneficial for those w/ UC. However, it looks as though the benefit may be only transitory while the patient is taking FMT.
- The prevalence of small intestinal bacterial overgrowth in diabetes mellitus: a systematic review and meta-analysis
- 14 studies, 1,417 diabetic patients, 649 healthy controls
- The pooled prevalence of SIBO in diabetic patients was 29% (OR 2.91 compared to controls)
- Commentary: Those w/ diabetes have a 2.9x higher risk of SIBO compared to healthy controls.
- Barrett’s esophagus surveillance in a prospective Dutch multi-center community-based cohort of 985 patients demonstrates low risk of neoplastic progression
- 985 Barrett’s esophagus patients followed x7.9 years
- 67 patients were diagnosed with high-grade dysplasia or cancer
- Progression rate to cancer = 0.78% per patient-year
- Commentary: Risk of progression to pre-cancer or cancer in those w/ Barrett’s esophagus is low.
- The effect of dehydroepiandrosterone (DHEA) supplementation on estradiol levels in women: A dose-response and meta-analysis of randomized clinical trials
- 21 studies, 1,223 participants
- DHEA supplementation led to higher estradiol levels in women >60 yo (+9.56 pg/mL)
- Especially when used at 50 mg/d and more than 26 weeks
- Commentary: DHEA supplementation may improve estradiol levels in post-menopausal women.
- Lipid profile in mild subclinical hypothyroidism: systematic review and meta-analysis
- 35 studies
- Mild subclinical hypothyroidism (TSH <10) was associated with poorer cardiometabolic markers:
- Total Cholesterol (+12.8 mg/dL)
- LDL-C (+11 mg/dL)
- Triglycerides (+19.3 mg/dL)
- HDL-C (-1.8 mg/dL)
- No difference in ApoB
- Commentary: Mild subclinical hypothyroidism is associated with a poorer lipid profile.
- Effects of Chronic Suppression or Oversuppression of Thyroid-Stimulating Hormone on Psychological Symptoms and Sleep Quality in Patients with Differentiated Thyroid Cancer
- Prospective study of 79 healthy controls, 191 patients w/ thyroid cancer on suppressive thyroid medication (thyroid medication meant to suppress TSH below reference range)
- Compared to healthy controls, those on thyroid suppressive therapy had:
- More symptoms
- Worse sleep
- Those w/ lower TSH had higher anxiety scores
- Commentary: Over-suppressing TSH is associated with worse sleep and more anxiety.
- An Open-Label, Pilot Trial of HRG80™ Red Ginseng in Chronic Fatigue Syndrome, Fibromyalgia, and Post-Viral Fatigue
- Open-label prospective study of 188 w/ chronic fatigue/fibromyalgia
- All took red ginseng supplementation
- After 30 days of supplementation:
- 67% increase in energy
- 48% increase in mental clarity
- 46% improvement in sleep
- 72% increase in physical stamina
- 33% decrease in pain
- Commentary: This study showed that red ginseng supplementation led to a significant improvement in chronic fatigue/fibromyalgia. Note that there was no testing performed before supplementation w/ this adaptogen.
- Intermittent fasting and continuous energy restriction result in similar changes in body composition and muscle strength when combined with a 12 week resistance training program
- 34 untrained participants allocated to 12 weeks of resistance training, and randomized to either:
- Continuous energy restriction (-20% Calories)
- Or 5:2 intermittent fasting (-70% Calories x2 days, normal Calories x5 days)
- Both groups ate a moderate amount of protein (>1.4g/kg)
- After 12 weeks, both groups had improvement of:
- Lean body mass (+3.7%)
- Weight (-4.6%)
- Fat (-24.1%)
- Muscular strength
- The continuous energy restriction group had a greater increase in muscle surface area
- Commentary: When using both resistance training and adequate protein, an intermittent fasting protocol leads to similar improvements in lean body mass, fat loss, and strength as compared to continuous energy restriction.
- 34 untrained participants allocated to 12 weeks of resistance training, and randomized to either:
- Clinical Outcomes After Discontinuation of Thyroid Hormone Replacement: A Systematic Review and Meta-Analysis
- 17 studies, 1,103 patients
- About 1/3 of patients undergoing thyroid hormone discontinuation remained euthyroid at follow-up (37.2%)
- Patients with a previous diagnosis of overt hypothyroidism were less likely to remain euthyroid (11.8%) than patients with a prior diagnosis of subclinical hypothyroidism (35.6%)
- Commentary: A substantial amount of patients on thyroid hormone remain euthyroid after discontinuing thyroid replacement therapy.
- Perturbations in Gut Microbiota Composition in Psychiatric Disorders: A Review and Meta-analysis
- 34 studies, 1,519 patients w/ psychiatric illness, 1,429 control participants
- Those w/ a psychiatric illness had a lower microbial diversity and richness in most but not all psychiatric diagnosis
- Commentary: This highlights the gut-brain connection.
- A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn’s Disease
- 194 Crohn’s Disease (CD) patients randomized to mediterranean diet (MD) or specific carbohydrate diet (SCD)
- After week 6, the SCD group had, NO difference in:
- Clinical remission rate (46.5% vs 43.5%)
- Fecal calprotectin remission (34.8% vs 30.8%)
- CRP remission rate (5.4% vs 3.6%)
- Commentary: This study showed NO difference between the MD and SCD for improving Crohn’s Disease. This is why we at the clinic follow a step-wise approach for dietary interventions (e.g. first start with a paleo diet before moving to a SCD).
- Evolution of gastroesophageal reflux disease symptoms after bariatric surgery: A dose-response meta-analysis
- 31 studies, 5,295 patients who had bariatric surgery
- 63.4% experienced improvement of reflux symptoms
- More improvements for Roux-en-Y gastric bypass
- Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial
- 293 participants w/ symptomatic COVID, randomized to probiotic or placebo
- After 30 days, the probiotic group had:
- Higher remission rate (53% vs 28%)
- Reduced nasopharyngeal viral load
- Less digestive and non-digestive symptoms
- Higher IgG and IgM SARS-CoV2 antibodies
- Commentary: High-quality study suggesting benefits of probiotics for COVID.
- A randomized double-blind placebo-controlled crossover pilot study: Acute effects of the enzyme α-galactosidase on gastrointestinal symptoms in irritable bowel syndrome patients
- 20 patients w/ IBS, randomized to placebo or α-galactosidase enzyme (Nogasin®, 1200 GaIU/meal) x3 standardized meals, then crossed over to other treatment arm
- Breath test measured every 30 minutes x7.5 hrs
- No difference in GI symptoms or hydrogen/methane levels between groups
- Commentary: In this cross-over pilot study, α-galactosidase enzyme was not superior to placebo.
- A Single Fasting Exhaled Methane Level Correlates With Fecal Methanogen Load, Clinical Symptoms and Accurately Detects Intestinal Methanogen Overgrowth
- Assessed the viability of using a single fasting breath methane level to diagnose intestinal methanogen overgrowth (IMO)
- Using the cutoff of ≥10 ppm, a single methane measurement had a:
- Sensitivity of 86.4%
- Specificity of 100% for diagnosing IMO
- And was associated with constipation
- Antibiotics led to a decrease of the fasting single methane measurement
- Single methane measurement was associated with higher stool M. smithii levels
- Commentary: A single methane breath level may be an accurate predictor of IMO, and correlates w/ M. smithii levels in the stool.
- Dr. Ruscio has been critical of some of Rao’s work on probiotics, however this study deserves praise as it has much clinical relevance.
- Regular Use of Proton Pump Inhibitor and the Risk of Inflammatory Bowel Disease: Pooled Analysis of 3 Prospective Cohorts
- Pooled analysis of 3 cohorts, including 647,407 participants
- Regular use of PPIs consistently showed a significantly positive association with both Crohn’s Disease and Ulcerative Colitis (HR 1.42)
- Systematic review with meta-analysis: the accuracy of serological tests to support the diagnosis of coeliac disease
- 113 studies, 28,338 participants
- Accuracy of celiac disease tests measured:
- IgA anti-tissue transglutaminase:
- Sensitivity: 90.7%
- Specificity: 87.4%
- IgA endomysial antibodies:
- Sensitivity: 88%
- Specificity: 99.6%
- IgA anti-tissue transglutaminase:
- Commentary: tTG IgA is more sensitive, and endomysial IgA is more specific for assessing celiac disease.
- A low FODMAP diet reduces symptoms in treated celiac patients with ongoing symptoms – a randomized controlled trial
- 70 celiac disease patients w/ persistent symptoms, randomized to low FODMAP diet, or gluten-free diet (control)
- After 4 weeks, the low FODMAP diet had:
- Lower IBS symptoms
- Less celiac disease symptom score
- Commentary: Those w/ celiac disease and persistent symptoms may benefit from a low FODMAP diet.
- Frequency of Celiac Disease in Patients With Chronic Diarrhea
- Cross-sectional study of 188 patients w/ chronic diarrhea (>3 months)
- Celiac disease was found in 12.2% of the individuals
- 21% of those w/ a family history of celiac disease developed the disease
- Commentary: A small (but notable) portion of those w/ chronic diarrhea may have diarrhea, especially if there is a family history of the disease.
- Human Herpesvirus 6 Infection and Risk of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis
- 11 studies
- Human herpesvirus 6 infection was associated w/ chronic fatigue
- Vitamin D and thyroid disorders: a systematic review and Meta-analysis of observational studies
- Examine the relationship between vitamin D levels and thyroid disorders
- Serum vit D levels were significantly lower in those with:
- Autoimmune thyroid disease (-3.1 ng/dL)
- Hashimoto’s (-6.1 ng/dL)
- Hypothyroidism (-13.4 ng/dL)
- No difference in those w/ Graves’ disease
- Commentary: This study showed lower Vit D levels in those w/ thyroid dysfunction, except for Graves’ disease.
- The effect of vitamin D supplementation on clinical symptoms and metabolic profiles in patients with endometriosis
- 60 women w/ endometriosis, randomized to Vit D (50,000 IU every 2 weeks) or placebo
- After 12 weeks of supplementation, the Vit D group had:
- Reduced pelvic pain
- Reduced CRP (-0.64 mg/L)
- Increase in total antioxidant capacity
- Commentary: Vit D may be beneficial for those w/ endometriosis.
- Effect of the phthalates exposure on sex steroid hormones in the US population
- 16 urinary phthalate metabolites and serum sex hormones measured in 1,768 adults
- Higher phthalate levels were associated w/ lower serum testosterone levels in males
- Commentary: Toxic burden may contribute to sex hormone dysfunction. Unfortunately, the effect size was unavailable in this study.
- Sleep disordered breathing as a risk factor for unnecessary pacemaker implantation
- 207 patients w/ cardiovascular disease at high risk for sleep disordered breathing (SDB)
- SDB confirmed in 84.5% (36% had severe SDB)
- Severe SDB was a predictor of the following during sleep:
- Third-degree AV block (OR 11.6)
- Second-degree AV block type 2 (Mobitz) (OR 4.5)
- Sinus bradycardia below 40 bpm (OR 3)
- Commentary: SDB may be a risk factor for heart arrhythmias.
- Improvements in Cognitive Function and Quantitative Sleep EEG in OSA after Six Months of CPAP Treatment
- 162 sleep apnea patients, measured cognitive function and EEG measurements before and after CPAP
- After 6 months of CPAP therapy
- ALL cognitive domains improved
- Enhanced EEG measurements
- Commentary: Treating sleep disordered breathing may improve cognitive function.
- A High Protein Diet Is More Effective in Improving Insulin Resistance and Glycemic Variability Compared to a Mediterranean Diet-A Cross-Over Controlled Inpatient Dietary Study
- 16 obese women, randomized to high protein (HP) or Mediterranean diet x10 days, then crossed over to the other diet x10 days
- Compared to the Mediterranean diet, the HP diet led to:
- Lower insulin (-7 µIU/mL)
- Less insulin resistance (HOMA-IR -1.8)
- Less glycemic variability
- Effects of Periodization on Strength and Muscle Hypertrophy in Volume-Equated Resistance Training Programs: A Systematic Review and Meta-analysis
- 35 studies comparing periodized vs non-periodized strength training
- Periodized strength training had:
- Better 1-rep max strength (effect size 0.31) in trained participants
- NO difference in muscle hypertrophy
- Commentary: Following a periodized (change in volume and intensity over time) strength training program may be better, as compared to non-periodized training. However, this may not make a big difference in an untrained population.
- Dr. Ruscio wanted to make the connection that periodization might make exercise unnecessarily complicated, much like some practices in GI and FM care.
- 3-Week passive acclimation to extreme environmental heat (100± 3 °C) in dry sauna increases physical and physiological performance among young semi-professional football players
- 36 male football players, randomized to no therapy or sauna therapy (3x/week for 9 total sessions)
- The sauna group had:
- Decreased body weight and body fat
- Increased hamstring flexibility and work capacity
- Better respiratory fitness
- Commentary: Sauna therapy may have beneficial effects for fitness, too.
- Small Intestinal Bacterial Overgrowth in Subclinical Hypothyroidism of Pregnant Women
- 224 pregnant women w/ subclinical hypothyroidism (SCH), 196 euthyroid pregnant women
- Lactulose breath test and thyroid function tests performed in all women
- Pregnant women w/ SCH had:
- HIGHER rate of SIBO (57% vs 32%)
- Higher CRP (7.8 vs 4.7)
- More GI symptoms
- Higher TPO antibodies (32 vs 11)
- Higher TSH (5.9 vs 5.3) and lower fT4 (13.5 vs 14.1)
- Commentary: SIBO is associated w/ SCH.
- Monocytosis Is a Biomarker of Severity in Inflammatory Bowel Disease: Analysis of a 6-Year Prospective Natural History Registry
- Prospective study of 1,290 patients with IBD (64.1% with Crohn’s disease; 35.9% with ulcerative colitis)
- Followed over 6 years
- Monocytosis (high monocytes on CBC) was found in 399 (30.9%) of patients with IBD
- 29.3% with Crohn’s disease
- 33.9% with ulcerative colitis
- Monocytosis was associated with:
- Elevated CRP and ESR levels
- Anemia
- Worse quality of life
- Longer time on biologic medications
- Higher financial costs
- Increased risk of hospitalization
- Commentary: High monocytes can be an indicator of higher disease activity in those w/ IBD.
- A randomized controlled trial to evaluate the effect of influenza vaccination and probiotic supplementation on immune response and incidence of influenza-like illness in an elderly population in Indonesia
- 554 healthy elderly adults, randomized to:
- Flu vaccine + probiotic
- Flu vaccine + placebo
- Probiotic + placebo
- Placebo + placebo
- The addition of probiotics to the flu vaccine had NO effect of influenza antibody titers
- Incidence of flu-like illness was NOT different between the probiotic group vs non-probiotic group
- Commentary: This study showed NO effect of probiotics for the flu.
- 554 healthy elderly adults, randomized to:
- Clinical Factors Associated With Positive Stool PCR for Gastrointestinal Pathogens in Celiac and Inflammatory Bowel Disease
- Retrospective of 92 w/ Celiac Disease and 174 w/ IBD
- All had PCR stool test to examine for GI pathogens
- Those w/ positive GI pathogen:
- Celiac Disease patients were more likely to:
- Have diarrhea (OR 2.6)
- Have extra-intestinal symptoms (OR 2.5)
- IBD patients were more likely to:
- Be on steroids (OR 2.2)
- Have extra-intestinal symptoms (OR 2.6)
- Use PPI (OR 4.1)
- Celiac Disease patients were more likely to:
- Commentary: Those w/ GI pathogens were more likely to have more complications of either Celiac Disease or IBD.
- Fecal Microbiota Transplant for Clostridioides Difficile Infection Is Safe and Efficacious in an Immunocompromised Cohort
- Retrospective study of 77 immunocompromised patients (62% had IBD)
- All had FMT
- Overall cure rate was 87%
- 12 patients received FMT for recurrent C. diff infection
- 3-month survival rate was 92%
- 11.7% had serious adverse events
- Commentary: FMT is both safe and effective for immunocompromised patients.
- Hydrogen and methane breath test results are negatively associated with IBS and may reflect transit time in post-surgical patients
- 525 glucose breath tests performed over 3 years in post-surgical patients
- 16% positive for hydrogen, 8% positive for methane
- Patients w/ IBS (HR 0.17) and those with a higher body mass index (HR = 0.93) were LESS likely to have a positive test
- Patients who underwent the test post-surgically were more likely to have a positive test (HR 2.76)
- Commentary: This study contradicts the most recent meta-analysis that shows an association between IBS and SIBO.
- Mediterranean Diet Adherence in People With Parkinson’s Disease Reduces Constipation Symptoms and Changes Fecal Microbiota After a 5-Week Single-Arm Pilot Study
- 8 Parkinson’s Disease (PD) patients, 8 healthy controls all put on Mediterranean diet
- After 5 weeks:
- Less constipation for those w/ PD
- No difference in intestinal permeability between 2 groups
- Proton pump inhibitors and risk of gastric cancer: population-based cohort study
- Prospective study of 973,281 new PPI users, and 193,306 new H2 blocker users
- Followed ~5 years
- The use of PPIs was associated with a 45% increased risk of gastric cancer compared with the use of H2 blockers (HR 1.45)
- The number needed to harm was:
- 2,121 for 5 years after starting treatment
- 1,191 for 10 years after starting treatment
- Commentary: Compared to H2 blockers (e.g. Pepcid), PPI use was associated w/ a higher risk of gastric cancer, although the absolute risk is low.
- Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study
- 738,881 participants who’ve used PPI therapy for >6 months
- Followed x5.3 years
- Those who had been on PPIs were more likely to have the following compared to non-PPI users:
- 206 (0.03%) developed gallbladder cancer
- 265 (0.04%) extrahepatic bile duct cancer
- 131 (0.02%) intrahepatic bile duct cancer
- Commentary: Longer-term PPI use may increase the risk of gallbladder and bile duct cancer.
- Proton pump inhibitor use and risk of depression and anxiety in children: nationwide cohort study
- 29,320 pairs of PPI users and non-users among children aged 7-17 years
- Kids who started PPI therapy had a higher rate of depression and anxiety (HR 2.61)
- Higher risk for longer use of PPI use
- Commentary: PPI use was associated w/ an increased risk of depression and anxiety in children. This highlights the gut-brain connection. However, causation CANNOT be inferred from this study.
- Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies
- Prospective analysis of 204,689 participants free of diabetes
- 10,105 cases of type 2 diabetes identified over 2.1 million person-follow up-years
- Regular PPI users had a 24% higher risk of diabetes than non-users (HR 1.24)
- Longer duration of PPI use was associated with higher diabetes risk
- PPI use 0-2 years (no increased risk)
- PPI use >2 years (HR 1.26)
- Commentary: PPIs may have a dose-dependent effect on diabetes risk.
- Effect of N-acetylcysteine on remission maintenance in patients with ulcerative colitis: A randomized, double-blind controlled clinical trial
- 168 ulcerative colitis (UC) patients on high-dose steroids and mesalamine
- Randomized to placebo or NAC (800 mg) and all patients had steroids tapered
- After 16 weeks of supplementation, the NAC group had:
- Less patients experience relapse (6 vs 19)
- Lower CRP, ESR
- Lower calprotectin
- Commentary: NAC may be a useful therapy for those w/ UC.
- Food Elimination in the Management of Refractory Chronic Rhinosinusitis: A Pilot Study
- 16 patients w/ chronic rhinosinusitis eliminated foods based off of IgE food allergy test
- After 12 weeks, there was a significant reduction in symptoms
- Commentary: Note that they used IgE testing (not IgG testing commonly used in popular food sensitivity tests).
- Chronic Intestinal Pseudo-Obstruction Is Associated with Intestinal Methanogen Overgrowth
- Retrospective study of 494 patients, all had glucose breath test
- 7.7% had intestinal pseudo-obstruction (rare motility disorder of dilated small bowel in the absence of mechanical obstruction)
- Prevalence of methane-positive SIBO was much higher in those w/ intestinal pseudo-obstruction (53% vs 12%)
- No difference in hydrogen SIBO between the 2 groups
- Commentary: Methane-positive SIBO can contribute to reduced GI motility.
- Diagnostic yield of esophagogastroduodenoscopy in France
- Survey of 342 gastroenterologists, including 2,735 endoscopies
- Most common findings on endoscopy:
- 32.8% normal
- 20.9% gastritis
- 18.1% hiatal hernia
- 13.7% esophagitis
- 4% Barrett’s esophagus
- 2.9% peptic ulcer
- 0.7% malignancy
- Commentary: The majority of endoscopies are normal. Only a small fraction find malignancy.
- Does Probiotic Consumption Enhance Wound Healing? A Systematic Review
- 4 studies, 348 participants
- All studies reported positive effects of probiotics improving wound healing
- NO adverse effects
- Probiotic Supplementation for Promotion of Growth in Children: A Systematic Review and Meta-Analysis
- 79 RCTs of probiotics used in kids 0-5 years old
- Probiotics had a small effect on increasing weight (effect size 0.26) and height (effect size 0.16)
- This beneficial effect was only seen in low-middle income countries (not in high-income countries)
- Commentary: Probiotics may be able to improve weight and height in kids who may be predisposed to malnutrition (e.g. kids who live in low-middle income countries).
- Association between Brachyspira and irritable bowel syndrome with diarrhoea
- 62 IBS patients, 31 healthy controls all had mucosal samples from sigmoid biopsy
- Brachyspira colonization was higher in the IBS group compared to healthy controls (31% vs 0%)
- Commentary: The spirochete Brachyspira was found more commonly in IBS patients compared to healthy controls.
- The Effect of Rice vs. Wheat Ingestion on Postprandial Gastroesophageal Reflux (GER) Symptoms in Patients with Overlapping GERD-Irritable Bowel Syndrome (IBS)
- Randomized crossover study in 21 patients with overlapping GERD-IBS
- Evaluated GERD symptoms after rice noodles (low FODMAP, gluten-free) w/ wheat noodles (high FODMAP, gluten), w/ 1-week washout period
- Wheat noodles were associated with:
- More reflux symptoms
- Higher H2 and CH4 breath test levels
- Commentary: Low FODMAP/gluten-free meals led to less intestinal gas levels and less reflux symptoms. A low FODMAP diet may be effective for reflux/GERD.
- Six vs 12 Sessions of Gut-focused Hypnotherapy for Irritable Bowel Syndrome: A Randomized Trial
- 448 IBS patients, randomized to 6 or 12 sessions of hypnotherapy
- No difference in those achieved >50% reduction in IBS symptoms (79% in 6 session group, 74% in 12 session group)
- Commentary: 6 sessions of hypnotherapy were non-inferior to 12 sessions in improving IBS symptoms.
- Impaired intestinal barrier function in type 2 diabetic patients measured by serum LPS, Zonulin, and IFABP
- 90 patients w/ type 2 diabetes (T2D), 28 healthy controls
- All intestinal permeability markers were HIGHER in the T2D group compared to the healthy controls
- Levels of elevation were associated w/ worse metabolic health
- Commentary: This highlights the gut-metabolic connection and the importance of foundational dietary practices for gut health.
- Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial
- Open-label study of 151 patients w/ heart failure (w/ reduced ejection fraction), randomized to:
- S. boulardii (500 mg BID)
- Rifaximin (550 mg BID)
- Or standard of care only
- After 3 months of treatment, no difference in:
- Ejection fraction
- Microbial diversity
- CRP levels
- Commentary: It’s surprising that there were no differences in microbial diversity, which makes us hesitant about the accuracy of this study.
- Open-label study of 151 patients w/ heart failure (w/ reduced ejection fraction), randomized to:
- Hyperthyroidism in Graves’ disease causes sleep disorders related to sympathetic hypertonia
- Prospective study of :
- 22 newly diagnosed Graves’ Disease (GD) with untreated hyperthyroidism
- 20 previously diagnosed with GD with normal thyroid function
- And 30 healthy controls
- Newly diagnosed GD patients started treatment and all followed x12 months
- At 12 month follow-up:
- Sleep quality was worse in untreated GD group
- Higher fT4 levels were associated with worse sleep quality
- Sleep quality improved by treating the GD group
- Commentary: Sleep quality can be impaired by hyperthyroidism and improved by treating it.
- Prospective study of :
- Effects of a Very Low-Carbohydrate High-Fat Diet and High-Intensity Interval Training on Visceral Fat Deposition and Cardiorespiratory Fitness in Overfat Individuals: A Randomized Controlled Clinical Trial
- 91 overweight participants, randomized to one of four groups:
- high-intensity interval training (HIIT)
- very low-carb diet (VLCD)
- combined HIIT + VLCD
- or control
- After 12 weeks, VLCD and combined HIIT + VLCD had greater reduction in:
- Visceral adipose tissue and body fat
- Waist/hip circumference
- Lean mass
- Commentary: A combined diet and exercise program may be superior compared to just one in isolation.
- 91 overweight participants, randomized to one of four groups:
- The effects of Silymarin on the features of cardiometabolic syndrome in adults: A systematic review and meta-analysis
- 11 RCTs
- Silymarin led to significant improvement in:
- Fasting blood glucose ( -17.96 mg/dL)
- A1C (-1.25%)
- Total cholesterol (-17.5 mg/dL)
- Triglycerides (-25.7 mg/dL)
- LDL-C (-10.5 mg/dL)
- HDL-C (+3.4 mg/dL)
- No difference in BMI
- Commentary: Silymarin is associated with improvement in most cardiometabolic markers.
- Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial
- 18,353 adults randomized to:
- Vitamin D3 (2000 IU/d)
- Omega-3 fatty acids (1 g/d)
- Or placebo
- After an average of 5.3 years of supplementation, no difference in mood or depression risk
- 18,353 adults randomized to:
- A Systematic Review and Meta-analysis of Randomized Control Trials: Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease
- 16 studies, 1,446 participants w/ GERD
- 727 receiving PPI only
- 719 receiving PPI + prokinetic
- The PPI + prokinetic resulted in greater improvement of GERD symptoms regardless of prokinetic type or GERD severity
- No difference in quality of life or adverse effects
- Commentary: PPI + prokinetic is superior to PPI alone in those w/ GERD.
- Dr. Ruscio wanted to add he has mixed emotions about prokinetics. He quickly checked this study and had his hesitancy reinforced by this quote:
- “In Asia, the most commonly used prokinetics are mosapride, itopride, and domperidone. However, another prokinetic agent, cisapride, has been withdrawn from the market owing to its association with fatal heart arrhythmia.”
- We aim to treat dysmotility further upstream, although still lacking robust data to support our approach.
- Dr. Ruscio wanted to add he has mixed emotions about prokinetics. He quickly checked this study and had his hesitancy reinforced by this quote:
- 16 studies, 1,446 participants w/ GERD
- On-demand Versus Continuous Maintenance Treatment of Gastroesophageal Reflux Disease With Proton Pump Inhibitors: A Systematic Review and Meta-analysis
- Aim: Compare on-demand (occasional use) vs continuous PPI therapy
- 11 studies
- Compared with continuous PPI therapy, on-demand therapy showed similar outcomes
- Especially in non-erosive reflux or mild reflux disease types
- However, in severe esophagitis, continuous PPI therapy was superior.
- Commentary: Given the potential adverse effect profile of PPIs, on-demand (occasional) PPI therapy may be preferential for milder versions of reflux
- Dental Caries Occurrence in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis
- 6 studies
- Those w/ IBD had higher rate of dental caries compared to healthy controls
- The effects of probiotic/synbiotic supplementation compared to placebo on biomarkers of oxidative stress in adults: a systematic review and meta-analysis of randomized controlled trials
- 31 trials, 1,681 participants
- Probiotics/synbiotics resulted in:
- Increased total antioxidant capacity
- Increased glutathione
- Commentary: Probiotics can exert antioxidant effects.
- Glutamine Supplementation Enhances the Effects of a Low FODMAP Diet in Irritable Bowel Syndrome Management
- 50 IBS patients, randomized to:
- Low FODMAP diet + placebo
- Low FODMAP diet + glutamine (15 g/d)
- After 6 weeks, the low FODMAP diet + glutamine group had significant improvement in IBS symptoms (58% reduction)
- Improvement in IBS-severity score of more than 45% was observed in 88% (vs 60% in low FODMAP + placebo)
- Commentary: Adding glutamine supplementation to a low FODMAP diet is superior to a low FODMAP diet alone. This is one of the mainstays of our clinic model.
- 50 IBS patients, randomized to:
- A Meta-Analysis of Microbial Therapy Against Metabolic Syndrome: Evidence From Randomized Controlled Trials
- 42 RCTs examining effect of microbial therapy (probiotics, prebiotics, FMT) for improving metabolic syndrome
- Microbial therapy resulted in:
- Reduced waist circumference (effect size -0.26)
- Reduced fasting glucose (effect size -0.35)
- Reduced total cholesterol (effect size -0.36)
- Reduced LDL-C (effect size -0.42)
- Reduced triglycerides (effect size -0.38)
- Increased HDL-C (0.28)
- No change in A1C or systolic blood pressure
- Commentary: This meta-analysis suggested that GI therapies can improve most metabolic parameters w/ a small effect size.
- Regular use of proton-pump inhibitors and risk of stroke: a population-based cohort study and meta-analysis of randomized-controlled trials
- Prospective study of 492,479 participants
- Documented 5,182 incidents of strokes over 3.1 million person-years of follow-up
- Regular PPI users had a 16% higher risk of stroke than non-users (HR 1.16, 95% CI 1.06 to 1.27)
- Commentary: Stroke is now identified as a potential adverse effect of PPI (along w/ enteric infections, fractures, and diabetes).
- Impact of 12-week exercise program on biomarkers of gut barrier integrity in patients with coronary artery disease
- 41 participants, measured gut permeability markers before and after exercise program
- After 12 week exercise program (aerobic exercise and resistance training):
- Increase in cardiorespiratory fitness (VO2 max) was associated with lower gut permeability levels
- Commentary: A foundational practice such as regular exercise can lead to improved gut health.
- Effect and Tolerability of a Nutritional Supplement Based on a Synergistic Combination of β-Glucans and Selenium- and Zinc-Enriched Saccharomyces cerevisiae (ABB C1 ®) in Volunteers Receiving the Influenza or the COVID-19 Vaccine: A Randomized, Double-Blind, Placebo-Controlled Study
- 72 participants, randomized to one of the following treatment given after COVID or flu vaccine:
- Placebo
- Or combined supplementation of S. cerevisiae probiotic, selenium, and zinc
- After 30 days of supplementation, the combined supplementation group had greater increases in IgG and IgM antibodies following the vaccine
- No adverse effects
- Commentary: A probiotic-containing supplement can improve the immune response to a viral vaccine.
- 72 participants, randomized to one of the following treatment given after COVID or flu vaccine:
- Role of Glucose Breath Test for Small Intestinal Bacterial Overgrowth in Children and Adolescents With Functional Abdominal Pain Disorders in Korea
- 68 kids w/ functional abdominal pain given glucose breath test
- 20.6% had SIBO
- Loose stools were more common in those w/ SIBO compared to those without SIBO
- Commentary: SIBO is not uncommon in children w/ functional abdominal pain. This study showed a correlation between SIBO and symptoms.
- Mast Cell Activation Disorder and Postural Orthostatic Tachycardia Syndrome: A Clinical Association
- 69 patients w/ POTS for >4 months
- 64% had additional non-orthostatic symptoms (migraine, allergies, skin rash, or GI symptoms)
- Of these patients, 66% had at least 1 lab abnormality suggesting MCAS
- 52% had elevated histamine markers
- Commentary: MCAS and histamine intolerance may be a contributing factor to POTS.
- The prevalence of intestinal dysbiosis in patients referred for antireflux surgery
- Retrospective study of 104 patients referred for reflux correction surgery
- All had lactulose breath test for SIBO
- 39.4% had SIBO, 35.6% had methanogen overgrowth
- Those w/ dysbiosis were more likely to have:
- Bloating (75% vs 49%)
- Belching (60% vs 34%)
- Commentary: SIBO may be a contributing factor to reflux.
- A Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder
- 20 patients w/ alcohol use disorder and cirrhosis randomized to placebo enema or FMT enema
- At 2 weeks follow-up:
- Alcohol cravings reduced significantly in 90% of FMT versus 30% in placebo
- FMT had reduced serum inflammatory markers
- At 6 month followup, placebo had HIGHER rates of serious adverse events (8 vs 2)
- Commentary: FMT may help improve alcohol cravings and have lower adverse events compared to placebo.
- Probiotics Supplementation on Cardiac Remodeling Following Myocardial Infarction: a Single-Center Double-Blind Clinical Study
- 44 patients with myocardial infarction who underwent percutaneous coronary intervention
- Randomized to probiotic or placebo
- After 3 months, the probiotic group had:
- Reduced markers of cardiac remodeling
- Greater improvements in echocardiogram findings
- Commentary: Probiotics may have beneficial effects on cardiac remodeling, suggesting a gut-heart connection.
- Efficacy and Safety of N-Acetylcysteine for the Management of Chronic Pain in Adults: A Systematic Review and Meta-Analysis
- 9 studies, 863 participants w/ chronic pain
- N-acetylcysteine did not reduce pain intensities
- Commentary: NAC may not have benefits for chronic pain.
- Elevated Levels of Circulating Biomarkers Related to Leaky Gut Syndrome and Bacterial Translocation Are Associated With Graves’ Disease
- 91 patients w/ Graves’ Disease, 44 healthy controls
- Measured markers of intestinal permeability
- Graves’ Disease patients had higher levels of intestinal permeability as compared to healthy controls
- Higher gut permeability levels were associated with:
- Higher antibody levels
- Lower TSH, higher fT4/fT3
- More symptoms
- Commentary: Another data point for the gut-thyroid connection.
- Carotid Intima-Media Thickness in Patients with Subclinical Hypothyroidism: A Prospective Controlled Study
- 54 total participants:
- 18 with subclinical hypothyroidism (SCH)
- Median TSH 6.15 µIU/ml
- 18 with overt hypothyroidism (OH)
- 18 healthy controls
- 18 with subclinical hypothyroidism (SCH)
- Carotid Intima-Media thickness (CIMT) measured in all participants
- Levothyroxine given to those w/ SCH
- Higher CIMT in SCH compared to healthy controls
- There was a decreased CIMT after levothyroxine treatment in those w/ SCH
- Commentary: Even w/ a TSH <10, those w/ SCH had:
- A higher CIMT
- Reduced CIMT scores after starting levothyroxine
- This is why research suggests considering levothyroxine in those w/ SCH who have a TSH between 7-10 and are younger.
- 54 total participants:
- Lower serum testosterone concentrations are associated with a higher incidence of dementia in men: The UK Biobank prospective cohort study
- 159,411 elderly men followed x7 years
- 826 developed dementia
- Lower total testosterone was associated with a higher risk of dementia (HR 1.43)
- Effects of vitamin D treatment on thyroid function and autoimmunity markers in patients with Hashimoto’s thyroiditis-A meta-analysis of randomized controlled trials
- 6 RCTs, 258 participants w/ Hashimoto’s
- Vitamin D supplementation resulted in:
- Reduced TPO Abs (-158.2)
- No difference in TSH, fT4, fT3
- Commentary: Another data point suggesting a benefit of Vitamin D for thyroid autoimmunity.
- The effect of vitamin D and exercise on balance and fall risk in postmenopausal women: A randomised controlled study
- RCT of postmenopausal women 50-70 y/o
- Women w/ low Vit D (<25nmol/L) randomized to 3 groups:
- Vit D supplementation
- Core and balance exercises
- Vit D + exercises
- Compared to 40 women w/ normal Vit D levels w/ no intervention
- After 8 weeks, all groups had improvement of balance and quality of life
- Evaluation of mandibular advancement device placement based on levels of TNF-alpha in participants with obstructive sleep apnea: A clinical study
- 20 patients w/ mild-to-moderate OSA given customized mandibular advancement device (MAD)
- After 6 months:
- Reduced inflammatory levels (TNF-alpha)
- Reduced daytime sleepiness
- Commentary: MAD can improve sleep apnea and reduce inflammation.
- Effects of a six-month low-carbohydrate diet on glycemic control, body composition and cardiovascular risk factors in patients with type 2 diabetes: an open-label RCT
- Open label study of 71 type 2 diabetics, randomized to low carb (20% carbs) or standard diet (higher carbs)
- After 6 months, the low carb group:
- Decreased carb intake by 30%
- Lower A1C (-2.8%)
- Reduced weight (-4 kg more than control)
- No change in lipids or blood pressure
- No episodes of severe hypoglycemia
- Commentary: A low carb diet (<20% carbs) is both safe and effective for type 2 diabetics.
- Comparison of the efficacy of intranasal ketamine versus intravenous ketorolac on acute non-traumatic headaches: a randomized double-blind clinical trial
- 140 participants w/ headache randomized to IV ketorolac or intranasal ketamine (0.75 mg/kg, max 75 mg)
- After 30 minutes, intranasal ketamine group had greater improvements in symptom severity
- Side effects (fatigue, dizziness, general discomfort, nausea, increased heart rate, and hypertension) were significantly higher in the ketamine group
- Commentary: Intranasal ketamine may have superior effects to improving headache compared to an IV NSAID medication, but has a greater risk of side effects.